By fiscal year 2030, the comptroller’s office forecasts the annual value of the tax break will be nearly $1.8 billion — a ...

-- Cebranopadol is an investigational first-of-its kind dual NOP/MOP receptor (dual-NMR) agonist which uses a novel approach of activating NOP and MOP receptors to work synergistically to treat pain ...

Highly experienced royalty specialists appointed as Chief Executive and Vice President as part of plan to establish a portfolio of precious metals royalties Stria Lithium Inc. is pleased to announce ...